Molecular and Cellular Pharmacology Student Seminars 2001-2002

Paul Nuzzi
Huttenlocher Lab
Pharmacology 901 Student Seminar
Monday, April 8, 2002
12:00 Noon
140 Bardeen


Understanding the Role of Cdc42 and Calpain in Neutrophil Chemotaxis and Chemokinesis


Neutrophils are a class of terminally differentiated leukocytes that comprise 60-80% of the total white blood cells circulating in the human blood. Neutrophil chemotaxis and activation are the first critical steps involved in innate immunity and are essential for fighting human infection. Defects in neutrophil response as well as chronic activation, plays a central role in illnesses such as: ischemia-reperfusion, heart disease, arthritis and asthma. In addition the absence of effective technology and hyper-reactivity of neutrophils make them difficult to work with and hard to manipulate. These obstacles have hampered our understanding of the mechanisms that regulate neutrophil chemotaxis and directional migration. Our lab has sought overcome these problems by developing new techniques that will allow us to study neutrophil chemotaxis. In order to utilize primary neutrophils, we have established a Tat mediated "Transit Peptide System" which allows for the introduction of full-length protein into neutrophils. Using several purification techniques and the process of protein conjugation we where able to demonstrate both internalization and in vivo function of V12Cdc42. This technology in combination with chemokinetic and chemotactic assays, allow us for the first time to manipulate and examine morphologic and signaling changes that occur during chemotactic migration in primary neutrophils This allows for manipulation of chemotactic cells using an established cell line. Recent evidence for our lab suggests that the Rho family GTPase Cdc42 and the calcium dependent cystine protease Calpain may play a central role in chemotactic migration. Using these new approaches we stand poised to finally begin to decipher and elucidate the underlying mechanisms of neutrophil chemotaxis.


References:
Allan et al. (1998) The Journal of Cell Science, Vol.141, 1147-1157
Servant et al., (1999) MBC, Vol. 10, 1163-1178
Glading et al., (2002) TCB, Vol 12, 46-54

Gerry Dodson
Tibbetts Lab
Pharmacology 901 Student Seminar
Monday, March 18, 2002
12:00 Noon
140 Bardeen

Regulation of ATR kinase activity and subcellular localization
In mammalian cells, the maintenance of genetic stability is achieved largely through the actions of genome surveillance mechanisms, which monitor the genome for the presence of abnormal DNA structures, including single-stranded DNA, DNA double-strand breaks (DSBs), and chemically modified DNA bases. Upon the detection of damaged DNA, these genome surveillance mechanisms initiate coordinated responses of cell cycle checkpoint activation and DNA repair, which together serve to minimize the chance that an incurred genetic lesion is irrevocably replicated and segregated during mitotic cell division. Defects in the detection, signaling, or repair of DNA damage can result in hypersensitivity to genotoxic stress and genetic instability. The long-term research goal of our laboratory is to define the mechanisms by which DNA damage is recognized and converted into regulatory signals in mammalian cells. Our studies are centered on a family of large molecular mass protein kinases that are distantly related to the catalytic subunit of PI3-kinase. Members of this family, including ATM (ataxia telangiectasia-mutated) and ATR (ATM-Rad3-related) function near the top of a genome surveillance network that initiates cell cycle arrest, DNA repair, and transcriptional responses in the face of genetic damage (1). Available evidence indicates that ATM and ATR regulate common downstream pathways in response to distinct, as well as partially overlapping forms of genotoxic stress. Current models place ATR upstream of p53 and the protein kinases Chk1 and Cds1, which regulate the DNA damage-activated G1/G2 phase cell cycle checkpoints.
My research interests are focused on the mechanisms that lead to ATR functional activation in response to genotoxic stress. Though enhancement of ATR catalytic activity in response to DNA damage has not been reported, the cellular localization of ATR changes dramatically. My project currently entails mapping the structural determinants that specify ATR localization to nuclear foci and attempting to identify the protein(s) responsible for targeting ATR to these subnuclear structures. Candidates being studied now include the ATR-interacting protein (ATRIP) identified by the Elledge group (2) as well as p130, a novel putative ATR-associated/DNA binding protein identified by our lab.

References:
1. Abraham, R. (2001) Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes and Development 15:2177-2196
2. Cortez, D., Guntuku, S., Qin, J., and Elledge, S.J. (2001) ATR and ATRIP: Partners in Checkpoint Signaling. Science 294:1713-1716

Siobhan Wilson
Laboratory of Patricia J. Keely
Pharmacoloy 901 Student Seminar
Monday, March 11, 2002
12:00 Noon
140 Bardeen


Integrin-associated protein (IAP/CD47) augments the function of 2ß1 integrin in smooth muscle cells (SMC), resulting in enhanced chemotaxis toward soluble collagen (Wang, X-Q., and W.A. Frazier. 1998. Mol. Biol. Cell. 9:865). IAP-deficient SMC derived from IAP-/- animals did not migrate in response to 4N1K (KRFYVVMWKK), a peptide agonist of IAP derived from the COOH-terminal domain of thrombospondin-1 (TSP1). When normal SMC were preincubated with 4N1K or an anti- 2ß1 function-stimulating antibody, cell migration to soluble collagen was significantly enhanced. 4N1K-induced chemotaxis was blocked by treatment of SMC with pertussis toxin indicating that IAP acts through Gi. In agreement with this, 4N1K evoked a rapid decrease in c! AMP levels which was intensified in the presence of collagen, and forskolin and 8-Br-cAMP both inhibited SMC migration stimulated via IAP. 4N1K strongly inhibited extracellular regulated kinase (ERK) activation in SMC attaching to collagen and reduced basal ERK activity in suspended SMC. Pertussis toxin treatment of SMC significantly activated ERK, suggesting that an inhibitory input was alleviated. Inhibition of ERK activity by (a) the MAP kinase kinase (MEK) inhibitor, PD98059, (b) antisense oligonucleotide depletion of ERK, and (c) expression of mitogen-activated protein (MAP) kinase phosphatase-1 in SMC all led to increased migration to collagen, 4N1K, or 4N1K plus collagen. Thus, IAP stimulates 2ß1 integrin-mediated SMC migration via Gi-mediated inhibition of ERK activity an! d suppression of cyclic AMP levels. Both of these signaling pathways could directly modulate the state of the integrin as well as impact downstream components of the cell motility apparatus.


Reference:
Xue-Qing Wang, Frederik P. Lindberg, and William A. Frazier
Integrin-associated Protein Stimulates 2ß1-dependent Chemotaxis via Gi-mediated Inhibition of Adenylate Cyclase and Extracellular-regulated Kinases
J. Cell Biol. 1999 147: 389-400.

Mike Gonzales
Richard Anderson Lab
Pharmacology 901 Student Seminar
Monday, March 11, 2002
12:00 Noon
140 Bardeen

Nuclear signaling by Ins(1,4,5) 3-Kinases


Inositol polyphosphate signaling begins with the creation of inositol 1,4,5 triphosphate ( Ins(1,4,5)P3) by phospholipases. Ins(1,4,5)P3 can then be acted upon by a series of kinases and phosphatases to create a wide array of potential second messengers. The initial phosphorylation event is mediated by a family of Ins(1,4,5)P3 3 kinases (IP3KA, IP3KB, and IP3KC) and the inositol polyphosate multi-kanase (IPMK). IPMK can continue to perform successive phosphorylations to create IP5 and PP-IP4, members of the family of higher inositols that are believed to act as second messengers in cells These inositol kinases are the initiators of higher inositol signaling and may represent an important regulatory junction. Recent evidence suggests that inositol polyphosphates and their associated kinases may play a unique role in nuclear signaling. To begin to define the role of the Ins(1,4,5)P3 in nuclear signaling we attempted to define the subcellular localization of the Ins(1,4,5)P3 kinases. Using polyclonal antibodies raised against full length IPMK, IP3KB, and IP3KC we have shown that they can be detected in the nucleus. Moreover, we have found all three localize to distinct structures within the nucleus that also contain proteins involved in RNA processing. Interestingly, preliminary evidence suggests that these foci may contain additional components that may represent an entire phosphoinosotide signaling pathway.

Akhil Bhalla
Chapman Lab
Pharmacology 901 Student Seminar
Monday, March 4, 2002
12:00 Noon
140 Bardeen


Metal Selectivity of Synaptotagmin-Membrane andSynaptotagmin-SNARE Interactions


Physiological studies show that divalent cations other than calcium induce secretion of neurotrasmitters form cells. The degree of secretion (potency and efficacy) varies with the type of metal used and also the cell type.

Our lab studies the function of Synaptotagmin and its role in exocytosis. We believe that synaptotagmin acts as the calcium sensor for secretion. We hypothesize that inorder for fusion to occur, synaptotagmin must bind phospholipids and SNAREs as a coupling step. Also, if these various metals induce secretion they probably do it by affecting the same or similar processes (i.e. membrane binding and SNARE binding). So we would like to use these metals to ask whether there is any correlation between the metal requirements for these individual steps (membrane binding and SNARE binding) to that which is observed in physiology (secretion from intact cells). If we see a correlation it could mean that synaptotagmins are the sensors for those metals in cells. If not, it could mean that there are other sensors present, or other effector molecules that work togther with synaptotagmin. In any case, this study will help us better understand the mechanism by which synaptotagmin facilitates neurotrasmitter release.

The assays I will use to address these questions are membrane penetration assays using fluorescent probes (AEDANS) and FRET.

Reference:
Ion selectivities of the calcium sensors for exocytosis in rat phaeochromocytoma cells
Kishimoto T. et al., Journal of Physiology (2001) 533.3 pp 627-637

Haichuan Duan
Jefcoate Lab
Pharmacology 901 Student Seminar
Monday, March 4, 2002
12:00 Noon
140 Bardeen

Steroidogenic Acute Regulatory Protein

mRNA turnover mediated by the major protein-coding-region determinant of instability (mCRD) of the c-fos proto-oncogene transcript illustrates a functional interplay between mRNA turnover and translation. We show that the function of mCRD depends on its distance from the poly(A) tail. Five mCRD-associated proteins were identified: Unr, a purine-rich RNA binding protein; PABP, a poly(A) binding protein; PAIP-1, a poly(A) binding protein interacting protein; hnRNP D, an AU-rich element binding protein; and NSAP1, an hnRNP R-like protein. These proteins form a multiprotein complex. Overexpression of these proteins stabilized mCRD-containing mRNA by impeding deadenylation. We propose that a bridging complex forms between the poly(A) tail and the mCRD and ribosome transit disrupts or reorganizes the complex, leading to rapid RNA deadenylation and decay.

Our lab is studying the Steroidogenic Acute Regulatory Protein (StAR), a critical mediator of de novo steroid hormone systhesis. StAR is subject to both transcriptional and post-transcriptional regulation, the latter one being more important in the acute phase of steoid hormone synthesis. We have evidence that StAR message stability is coupled to ongoing translation, and several mCRD-like elements within the StAR coding region and 3'UTR have recently been identified, suggesting a mechanism close to c-fos mRNA regulation.

Reference
Christophe Grosset, C.-Y. A. C., Nianhua Xu, Nahum Sonenberg, Helene Jacquemin-Sablon, and Ann-Bin Shyu (2000). "A Mechanism for Translationally Coupled mRNA Turnover: Interaction between the Poly(A) Tail and a c-fos RNA Coding Determinant via a Protein Complex." Cell 103: 29.

David Watrous-McCabe
Sheets Lab (Biomolecular Chemistry)
Pharmacology 901 Student Seminar
Monday, February 25, 2002
12:00 Noon
140 Bardeen


Understanding the Regulation of Spemann's Organizer by FGFR

Elucidating the molecular mechanisms that regulate vertebrate development is the primary goal of the work in the Sheets lab. In order for the normal development of a multicellular organism to occur, cell-cell signaling events must take place to instruct cells where to go and what to become. Spemann's organizer is an essential inducing center in the Xenopus functioning organizer developing embryos show reduced cell differentiation and body axis definition. The presence of an ectopic organizer can by itself induce secondary body axes in host tissues. Thus showing that the signals that emanate from the organizer are sufficient to direct development [1]. Our lab has demonstrated that a key regulator of organizer function is the fibroblast growth factor receptor (FGFR) signaling pathway [2]. The specific goal of my work is to elucidate the mechanism by which FGFR regulates signaling in the organizer, as well as to determine how the signals that emanate from the organizer are regulated during development. In order to elucidate the features of FGFR responsible for downstream signaling I am using mutant receptor constructs in the organizer and assaying organizer function. This focus of my research will allow me to understand what properties of FGFR mediate its ability to transduce specific signals. To determine how signaling down stream of FGFR regulates development I am trying to determine how the organizer specific gene chordin is regulated. Our lab has demonstrated that FGFR is a regulator of the transcription of chordin [2]. This provides a good starting point from which I can determine how organizer specific genes are regulated by FGFR.

References:
1. Gerhart, J., Evolution of the Organizer and the chordate body plan. International Journal of Developmental Biology, 2001. 45: p. 133-153
2. Mitchell, T.S. and M.D. Sheets, The FGFR Pathway Is Required for the Trunk-Inducing Properties of Spemann's Organizer. Developmental Biology, 2001. 237(2): p. 295-305.

DeannaLee Beauvais
Rapraeger Lab
Pharmacology 901 Student Seminar
Monday, February 18, 2002
12:00 Noon
140 Bardeen

Syndecan-1 Adhesion Mediated Signaling in Human Breast Carcinomas


Syndecans are a family of four distinct, but homologous, type I transmembrane cell surface heparan sulfate proteoglycans. These receptors are expressed in all adherent cells and have been attributed important regulatory roles in cellular differentiation, proliferation, cell-cell/cell-matrix adhesion, cell migration and regulation of cell morphology. Endowed by their heparan sulfate (HS) chains, syndecans interact with components of the extracellular matrix (ECM). Through these binding interactions, syndecans can act as co-receptors to modify integrin-ECM adhesions, but can also influence intracellular signaling events to elicit changes in the cortical actin cytoskeleton. Though it is clear that the syndecan HS chains are essential for matrix binding, less is known about the role the syndecan core proteins play in cell adhesion signaling. The focus of my research is to investigate how cis protein-protein interactions of the syndecan-1 core protein mediate the formation of macromolecular cell adhesion and signaling complexes that regulate organization of the actin cytoskeleton. 
MDA-MB-231, a highly invasive human mammary carcinoma cell line, endogenously express syndecan-1, -2 and -4 at their cell surface, along with a wide complement of b1 integrins and modest levels of the primary vitronectin receptor, avb3. These cells will strongly adhere to a monoclonal antibody (B-B4) directed against the extracellular domain of the syndecan-1 core protein, but fail to spread. Though the MDA-MB-231 initially fail to spread in response to syndecan-1 ligation, these cells can be induced to spread in response to 1mM Mn2+ (an exogenous activator of integrins) or with function blocking b1 integrin antibodies (P5D2 or mAb13). This cell spreading occurs in the absence of an integrin ligand, yet requires avb3 integrins activity as treatment with a soluble avb3 integrin blocking antibody (LM609) inhibits spreading. Interestingly, recent studies indicate that cell spreading is dependent on a region located within the ectodomain of the syndecan-1 core protein. These results suggest that anchorage of syndecan-1 to extracellular matrix ligands initiates formation of a syndecan-1/avb3 integrins signaling complex that mediates reorganization of the actin cytoskeleton. Further, our results suggest that the failure of these cells to spread in response to syndecan-1 ligation is due to transdominant inhibition of avb3 integrins by constitutively active b1 integrins on the surface of these cells. This phenomenon may be a critical regulator of invasiveness in mammary carcinoma cells.

Reema Jasuja
Greenspan Lab
Pharmacology 901 Student Seminar
Monday, February 11, 2002
12:00 Noon
140 Bardeen


Creation of a Sog Morphogen Gradient in the Drosophila Embryo


A variety of genetic evidence suggests that a gradient of decapentaplegic (Dpp) activity determines distinct cell fates in the dorsal region of the drosophila embryo, and that this gradient may be generated indirectly by an inverse gradient of the BMP antagonist Short gastrulation (Sog). It has been proposed that the Sog diffuses dorsally from the lateral neuroectoderm where it is produced and is cleaved and degraded dorsally by the metalloprotease Tolloid (Tld). In this paper, it has been shown directly that Sog is distributed in a graded fashion in dorsal cells and that Tld degradation limits the level of Sog dorsally. In addition, the paper discusses the dynamin dependent retrieval of Sog which acts in parallel with degradation by Tld as a dorsal sink for active Sog.

Reference:

Shaila Srinivasan, Kay E Rashka and Ethan Bier, Developmental Cell, Vol.2, 91-101, Jan 2002.

Beth Chang
Miyamoto Lab
Pharmacology 901 Student Seminar
Monday, February 11, 2002
12:00 Noon
140 Bardeen

NFkB Activation Induced by DNA Damaging Agents: Mechanistic Investigation of Super-induction by TPA

The transcription factor NF-kB was originally found in mature B cells as a nuclear protein having the ability to enhance the transcription of the k light chain gene. Since then, NF-kB has been found in various cell types as a complex in the cytoplasm with its inhibitor protein, IkB. IkBa degradation can be stimulated by a variety of agents, including: pro-inflammatory molecules, pro-oxidants, and DNA damaging agents. Inducible NF-kB activity is initiated by degradation of its inhibitor protein, IkB. Induction of NF-kB activity by pro-inflammatory agents is known to induce a phosphorylation cascade. This cascade leads to a site-specific phosphorylation of IkB by IkB kinase (IKK), followed by ubiquitination, and 26S proteasome-mediated degradation. Free NFkB undergoes nuclear translocation and can activate target genes with a kB DNA binding site.
DNA damaging agents also activate PKC. A correlation between PKC activity and NFkB activity has been demonstrated, but there is no evidence that PKC might be modulating components in the NFkB cascade directly.
TPA is a phorbol ester that activates NFkB. It is a very potent tumor promoter known to activate various PKC isoforms including PKCa, bI, bII, g, d, e, h, q and m. A short-term treatment of TPA induces translocation of various PKCs from the cytoplasm to the membrane where they become activated by auto-phosphorylation.
I down-regulated PKC by prolonged TPA treatment. I pre-treated human T cells (CEMp) with TPA for 21 hours prior to the addition of VP16 (treated for 3 additional hours). NFkB activity in the TPA treated cells was five times higher than the cells treated with VP16 alone despite the fact that PKCs (a, b) have been down-regulated. This activation of NFkB is termed ìsuper-inductionî. My research goal has been focused on determining the underlying mechanism and functional consequence of this "super-induction" phenomenon.

References:
1. Silverman N. and Mandates T. Genes and Development, 15:2321-2342
2. Chapman D. Pate A. Heissmeyer V and Scheidereit C. , MCB 21 (19) 6640-6650

Jared Causey
Kamp Lab
Pharmacology 901 Student Seminar
Monday, February 4, 2002
12:00 Noon
140 Bardeen


Differentiation of Embryonic Stem Cell-Derived Cardiomyocytes (SCDCs)


The observation that embryonic stem (ES) cells, when allowed to differentiate, produced areas of spontaneously contracting cells has opened up a new system to study mammalian cardiac development. Much work has been done with mouse embryonic stem cells. However, the isolation of primate ES cell lines allows for new studies that more closely mimic human cardiac development.
The embryoid body culture system has been widely used to produce cardiomyocytes from mouse ES cells. In this system, spontaneous contraction begins approximately one week after the cells begin to differentiate. Cardiac markers (a-MHC, b-MHC, MLC-2v, etc.) are seen to increase both from RT-PCR and immunostaining experiments. Electrophysiological studies help to confirm the presence of functional cardiomyocytes. Comparison to mouse fetal tissue suggests the system's validity as a model for cardiac development. Using a modified embryoid body system, we are currently attempting to differentiate and characterize cardiomyocytes from human and rhesus ES cells.

References:


Doevendans et al.  Differentiation of Cardiomyocytes in Floating Embryoid Bodies is Comparable to Fetal Cardiomyocytes.  J Mol Cell Cardiol 32:839- 851, 2000.

Kehat et al.  Human Embryonic Stem Cells Can Differentiate into Myocytes with Structural and Functional Properties of Cardiomyocytes.  J Clin Invest 108(3):407-414, 2001.

Lina Kwong
Pharmacology 901 Student Seminar
Monday, January 28, 2002
12:00 Noon
140 Bardeen

R-Ras Enhances Integrin-Mediated Signaling to FAK and p130Cas to Promote Migration


The a2b1 integrin mediates signaling events that determine whether an epithelial cell will polarize or migrate. Changes in a2b1 integrin expression can disrupt cell polarization, which may lead to uncontrolled cell migration and invasion. The small GTPase, R-Ras, has been shown to promote a2b1 integrin mediated cell adhesion and migration in breast epithelial cells (Keely, et al. 1999, JCB 145:1077). It is unknown how R-Ras regulates these integrin mediated signaling events. Integrin mediated cell migration and adhesion to the extracellular matrix involves forming focal adhesions and signaling to molecules such as focal adhesion kinase (FAK) and p130Cas. In human breast carcinomas, T47D cells, we found that activated R-Ras enhanced focal adhesion formation and the phosphorylation of FAK and p130Cas mediated by a2b1 integrins. I will discuss the following three possible mechanisms by which R-Ras may enhance FAK and p130Cas phosphorylation: (1) R-Ras conformationally changes the integrin receptor to induce higher affinity binding of ligand, (2) R-Ras clusters integrins to increase the avidity to induce an increase in receptor ligand binding, and (3) R-Ras activates direct signaling pathways. Our data suggests that R-Ras enhances FAK and p130Cas phosphorylation and focal adhesion formation by a novel mechanism that differs from but also synergizes with the a2b1 integrin.


References:

Keely, P.J. et al., 1999. R-Ras Signals through Specific Integrin a Cytoplasmic Domains to Promote Migration and Invasion of Breast Epithelial Cells. JCB 145(5): 1077-1088

Giancotti, F.G. and E. Ruoslahti 1999. Integrin Signaling. Science 285: 1028-1032.

Bernice Lin
Bradfield Lab
Pharmacology 901 Student Seminar
Monday, December 17, 2001
12:00 Noon
140 Bardeen


Understanding the AhR Pathway


The aryl hydrocarbon receptor (AHR) is a prototype member of the PAS (Per-Arnt-Sim) superfamily of proteins. In addition to the signature PAS domain of 200 amino acids, members of this superfamily commonly have a bHLH domain that recognizes and binds specific DNA sequences in enhancer elements. The Aryl Hydrocarbon Receptor (AHR) is known for its ability to mediate toxic effects of industrial chemical byproducts such as halogenated and polycyclic aromatics (i.e. Dioxin). The outcomes of exposure to AHR agonists include, induction of xenobiotic metabolizing enzymes, teratogenicity, immune suppression, tumor promotion, and death. Despite the recognized involvement of AHR in such effects, the causal molecular pathway to toxicity still remains unclear. What also remains unresolved is the true physiological role of the AHR. However, recent work on the AHR-/- does suggest importance in hepatic vasculogenesis.
In the unliganded state, the AHR exists in the cytoplasm, bound to a dimer of hsp90, and Ara9. Previous work has shown hsp90's involvement with AHR to be important in maintaining the correct conformational state for ligand binding. However, the role of Ara9 in the AHR pathway is still unclear. It may be interacting to stabilize AHR, or function as part of a DNA binding complex; important in recruitment of cofactors, or may be acting to mask the nuclear localization sequence (NLS) of the AHR; thereby inhibiting nuclear transport. Developmentally, Ara9 is expressed prior to, as well as in tissues distinct from AHR expression. Therefore, Ara9 may play a role outside of the AHR pathway.

One ongoing project is creating a conditional Ara9 knockout mouse. We hope that a knockout will shed light on the importance of Ara9 in the AHR pathway, as well as provide insight into other roles for the Ara9 protein in development. 
Previous work in our lab gives evidence for a masked nuclear localization signal which can be unmasked by insertions within the a-helix at the basic region of the bHLH domain of AHR. As previously stated, Ara9 may be responsible for masking of this nuclear localization signal. We are working on construction of DNA-binding mutants of the AHR by inserting alanine's at this bHLH site and thereby rotating the helix to uncover a masking/unmasking phenomenon. These DNA-binding mutants will also prove useful in studying the role of AHR DNA-binding in transactivation of genes important in either the toxic, adaptive, or endogenous AHR pathway.

References:
1. Carver, L.A., LaPres, J.J., Jain, S., Dunham, E.E., and Bradfield, C.A. (1998) J. Biol. Chem. 273:33580-87.
2. Gu, Y-Z, Hogenesch, J.B., and Bradfield, C.A. (2000) Annu. Rev. Pharmacol. Toxicol. 40:519-61.
3. Petrulis, J.R., Hord, N.G., and Perdew, G.H. (2000) J. Biol. Chem. 275:37448-53.

 

DeannaLee M. Beauvais
Pharmacology 901 Student Seminar
Monday, December 10, 2001
12:00 Noon
140 Bardeen


Syndecans are a family of four distinct, but homologous, type I transmembrane cell surface heparan sulfate proteoglycans. These receptors are expressed in all adherent cells and have been attributed important regulatory roles in cellular differentiation, proliferation, cell-cell/cell-matrix adhesion, cell migration and regulation of cell morphology. Endowed by their heparan sulfate (HS) chains, syndecans interact with components of the extracellular matrix (ECM). Through these binding interactions, syndecans can act as co-receptors to modify integrin-ECM adhesions, but can also influence intracellular signaling events to elicit changes in the cortical actin cytoskeleton. Though it is clear that the syndecan HS chains are essential for matrix binding, less is known about the role the syndecan core proteins play in cell adhesion signaling. The focus of my research is to investigate how cis protein-protein interactions of the syndecan-1 core protein mediate the formation of macromolecular cell adhesion and signaling complexes that regulate organization of the actin cytoskeleton. 
MDA-MB-231, a highly invasive human mammary carcinoma cell line, endogenously express syndecan-1, -2 and -4 at their cell surface, along with a wide complement of b1 integrins and modest levels of the primary vitronectin receptor, avb3. These cells will strongly adhere to a monoclonal antibody (B-B4) directed against the extracellular domain of the syndecan-1 core protein, but fail to spread. Though the MDA-MB-231 initially fail to spread in response to syndecan-1 ligation, these cells can be induced to spread in response to 1mM Mn2+ (an exogenous activator of integrins) or with function blocking b1 integrin antibodies (P5D2 or mAb13). This cell spreading occurs in the absence of an integrin ligand, yet requires avb3 integrins activity as treatment with a soluble avb3 integrin blocking antibody (LM609) inhibits spreading. Interestingly, recent studies indicate that cell spreading is dependent on a region located within the ectodomain of the syndecan-1 core protein. These results suggest that anchorage of syndecan-1 to extracellular matrix ligands initiates formation of a syndecan-1/avb3 integrins signaling complex that mediates reorganization of the actin cytoskeleton. Further, our results suggest that the failure of these cells to spread in response to syndecan-1 ligation is due to transdominant inhibition of avb3 integrins by constitutively active b1 integrins on the surface of these cells. This phenomenon may be a critical regulator of invasiveness in mammary carcinoma cells.

Kyle McQuade
Pharmacology 901 Student Seminar
Monday, December 3, 2001
12:00 Noon
140 Bardeen

Syndecan-1 Mediated Raji Cell Spreading Requires Signaling Through Lipid Raft


Members of the syndecan family of cell-surface transmembrane proteoglycans play important roles in a variety of cellular processes including growth factor signaling, cell-cell adhesion, and the regulation of cell shape. However, the roles the syndecan core proteins play in these processes are not well-understood. The focus of my research is to understand the mechanism by which syndecan-1 regulates reorganization of the actin cytoskeleton. Raji-S1 cells, lymphoblastoid cells transfected to express syndecan-1 as their sole proteoglycan, bind to and rapidly spread on syndecan-1 ligands such as thrombospondin, fibronectin, and a monoclonal antibody directed against the syndecan-1 ectodomain. Parental cells do not spread on syndecan-1 ligands. We have expressed a panel of mutated syndecan-1 molecules in order to assess their ability to generate a spreading response. Truncation of the syndecan-1 extracellular or cytoplasmic domain fails to inhibit spreading, suggesting an important role for the syndecan-1 transmembrane. Furthermore, spreading is blocked by methyl-beta cyclodextrin, which disrupts lipid raft structure. Syndecan-1 is also co-isolated with known lipid-raft markers. Taken together, these data suggest a novel mechanism by which syndecan-1 regulates cell shape.

Erik Peden
Laboratory of Maureen Barr
Pharmacology 901 Student Seminar
Mon. Nov 26, 12pm
140 Bardeen


MAKING SENSE OF WORM SEX

All higher organisms have evolved specialized sensory cells and receptors for perceiving selective features of their external environment to ultimately coordinate behaviors for survival and reproduction. While the cellular bases of sensory systems are well characterized, less is understood about the genes and proteins responsible for sensory detection. Our lab is using male mating behavior of C. elegans as a model system to study the genes, proteins and cells involved in sensory mediated behaviors.

To identify genes required for male mating behavior, we are undertaking a candidate gene approach and are surveying the cellular expression profiles of all 13 C. elegans TRP genes to see if they are expressed in male specific sex sensory cells. This family of genes encodes 6 TM domain ion channels, some of which have been shown to be important for sensory behaviors in C. elegans and other organisms (1, 2). In addition, available TRP mutant strains are being put through behavioral assays to see if males exhibit defects in mating. Expression data so far suggests that the TRP channels osm-9 and ocr-2 are expressed in subsets of male-specific sex sensory cells, including spicule and ray neurons. Behavioral data supports a role for these channels in these cells, as the males are unresponsive to hermaphrodite contact (a ray behavior) and are often unable to insert their copulatory spicules into their mates' vulva.

In parallel with the candidate gene approach, we are utilizing a forward genetics approach to clone new genes involved in male mating. A mutant strain sy511 was originally isolated from a mating behavior screen based on its abnormal responsiveness to contact with hermaphrodites, and we are in the process of mapping it genetically. It will be ultimately cloned by cosmid rescue, which will then make it possible to determine the molecular lesions that result in abnormal mating behavior. By using a combination of both forward and reverse genetic approaches, we hope to unravel the molecular basis of sensory behaviors.

Bibliography:
1) Harteneck, C., Plant TD, and Schultz, G. From worm to man: three subfamilies of TRP channels. TINS. 23 (4): 159-166.

2) Colbert, HA, Smith, TL, Bargmann, CI. (1997)   OSM-9, a novel protein with structural similarity to channels, is required for olfaction, mechanosensation, and olfactory adaptation in Caenorhabditis elegans. J Neurosci. 17 (21):8259-69.

Julie Sommer
Pharmacology 901 Student Seminar
Monday, November 19, 2001
140 Bardeen

 

Thesis Defense

P2X7 Purinergic Receptor Modulation of LPS-Stimulated Macrophage Activation

During Gram-negative bacterial sepsis, bacterial lipopolysaccharide (LPS, endotoxin) activates macrophages to produce a variety of inflammatory mediators. These macrophage products are critical in the host defense against bacterial infection, but when produced in excessive amounts can promote lethal septic shock. Although many of the physiological consequences of the LPS activation of macrophages and the signal transduction pathways involved have been defined, the exact proximal mechanisms by which LPS activates macrophages appear to be complex and remain to be elucidated. Extracellular adenine nucleotides, such as ATP, can be present at high local concentrations during inflammation, and have a modulatory role in the macrophage and host response to LPS. The exact purinergic receptors involved were unknown until recently; however, evidence from our laboratory and others suggests that the P2X7 receptor, an ATP-gated ion channel, has a role in macrophage activation by LPS.

We have observed that antagonism of the P2X7 purinergic receptor attenuates several LPS-stimulated signal transduction events as well as up-regulation of the inducible form of nitric oxide synthase and the subsequent release of nitric oxide from the macrophage, an event that requires the activation of the transcription factor NF-kB. Because P2X7 blockade has a profound effect on LPS signaling events, we tested the hypothesis that P2X7 activation can alone induce some of these signal transduction pathways. It was observed that activation of P2X7 with the selective agonist 3'-O-(4-benzoyl)benzoic ATP (BzATP) is sufficient for activation of NF-kB in RAW 264.7 murine macrophages. In addition, BzATP, like LPS, mediates this effect in part through the degradation of the alpha isoform of the inhibitor of NF-kB (IkBa). Although the kinetics of LPS- and BzATP-stimulated NF-kB activation differ, the composition of the NF-kB complex is similar, suggesting that convergence of P2X7 and LPS-mediated pathways is possible. Further investigation utilizing Chinese Hamster Ovary fibroblasts that stably express the LPS-binding protein CD14 (CHO/CD14 cells) reveals that select P2X7-stimulated signaling pathways are potentiated by CD14 expression. These observations are consistent with the involvement of P2X7 in LPS signaling in macrophages.

Additionally, our sequence analysis of the long cytoplasmic C-terminus of P2X7 has revealed many potential sites for phosphorylation and the docking of signaling and adaptor proteins, an observation consistent with a direct role of P2X7 in signaling events apart from its ion channel activity. Most interestingly, the extreme C-terminus of P2X7 contains a highly conserved LPS-binding motif, suggesting a direct interaction between P2X7 and LPS. Peptides corresponding to this P2X7 LPS-binding motif bind LPS in vitro. Mutation of adjacent arginine and lysine residues to glutamic acid residues in this peptide abolish LPS binding. Based on this observation, we were interested in determining the effect of this mutation in the context of the whole protein. Mutant proteins (P2X7-EE) expressed in HEK293 cells have temperature-sensitive trafficking defects. Assessment of the function of the P2X7-EE mutant in cells grown at the permissive temperature reveals that BzATP-stimulated pore formation and cell death is abolished, but that ion channel activity is intact at a reduced level. These observations indicate that the P2X7 LPS-binding motif is important for P2X7 protein processing as well as in the function of the protein. The potential role of this motif in LPS signaling is currently under investigation. In summary, these data not only support the involvement of the P2X7 purinergic receptor in LPS-stimulated events, but also suggest that the interaction between LPS and the P2X7 receptor is direct.

References:

Sommer JA, Watters JJ and PJ Bertics (2001) P2X7 Receptor-Initiated NF-kB and MAP Kinase Activation: Involvement of IkBa and the LPS-Binding Protein CD14. (submitted).

Denlinger LC, Fisette PL, Sommer JA, Watters JJ, Prabhu U, Proctor RA and PJ Bertics. (2001) Cutting Edge: The Nucleotide Receptor P2X7 Contains Multiple Protein- and Lipid-Interaction Motifs Including a Potential Binding Site for Bacterial Lipopolysaccharide. J. Immunol. 161: 1871-1876.

Watters JJ, Sommer JA, Fisette PL, Pfeiffer ZA, Aga M, Prabhu U, Guerra AN, Denlinger LC and PJ Bertics (2001) The P2X7 Nucleotide Receptor: Modulation of LPS-Induced Macrophage Signaling and Mediator Production.  Drug Dev. Res. 53: 91-104.

Watters JJ, Sommer JA, Pfeiffer ZA, Prabhu U, Guerra AN and PJ Bertics. (2001) A Differential Role for the Mitogen-Activated Protein Kinases in LPS Signaling: The MEK/ERK Pathway Is Not Essential For Nitric Oxide and Interleukin-1b Production. (submitted).

Sommer JA, Fisette PL, Hu Y, Denlinger LC, Guerra AN, Bertics PJ and RA Proctor. (1999). Purinergic receptor modulation of LPS-stimulated signaling events and nitric oxide release in RAW 264.7 macrophages.  J. of Endotoxin Res. 5(1-2):70-74.

Hu Y, Fisette PL, Denlinger LC, Guadarrama AG, Sommer JA, Proctor RA and PJ Bertics. (1998) Purinergic Receptor Modulation of Lipopolysaccharide Signaling and Inducible Nitric Oxide Synthase Expression in RAW 264.7 Macrophages.  J. Biol. Chem. 273(42):27170-27175.

Denlinger LC, Garis KA, Sommer JA, Guadarrama AG, Proctor RA and PJ Bertics. (1998) Nuclear Translocation of NF-kappa-B in Lipopolysaccharide-treated Macrophages Fails to Correspond to Endotoxicity-Evidence Suggesting a Requirement for a Gamma Interferon-Like Signal.  Inf. & Immun. 66(4):1638-164

Blue-leaf Hannah
Pharmacology 901 Student Seminar
Monday, November 12, 2001
140 Bardeen
12:00 Noon

Characterization of the Calcium Binding C-Terminus of Thrombospondins

Thrombospondin (TSP) 1 and 2 are members of a family of multi-modular extracellular matrix glycoproteins that play roles in diverse physiological and pathophysiological processes. TSP1 is released from platelet__-granules and is expressed in atherosclerotic lesions. Similar in structure to TSP1, TSP2 is expressed in marrow stromal cells and fibroblasts of skin granulation tissue. Although TSP1 and TSP2 are found in pathological lesions, TSP5 is the only member of the TSP family to be directly linked to disease. Missense mutations localized to the C-terminal 480 residues of TSP5 result in pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia (MED). A pathological feature of PSACH and MED is the accumulation of mutant TSP5 in the endoplasmic reticulum of chondrocytes. It is therefore likely that missense mutations in this region of other TSPs could cause similar inclusions.

The literature indicates that the calcium binding C-terminal half of TSPs is extremely labile. In order to further understand this lability, we chose to study TSP2. TSP2 is the only TSP with paired cysteines, decreasing the likelihood of disulfide bond isomerization in this region. We characterized the intrinsic fluorescence of the calcium binding
C-terminus of human TSP2 as a function of calcium concentration. Using a recombinant baculovirus system, we expressed E3CaG2 that contains the last of the three EGF repeats of TSP2 (E3), the 7 aspartate-rich calcium binding (type 3) repeats (Ca), and the globular tail (G). We also expressed the type 3 repeats alone (Ca2), the type 3 repeats plus the globular tail (CaG2), and a truncated version of CaG2 (tCaG2) lacking the W682 and the first type 3 repeat. Intrinsic fluorescence of Ca2, CaG2, and tCaG2 was different from each other and markedly different from E3CaG2 suggesting that the E3 EGF repeat may modulate the calcium-dependent conformation of the type 3 repeats. In addition, based on the finding that the fluorescence of 6 tryptophans in the globular tail was perturbed by calcium, we propose that E3 EGF repeat, the type 3 repeats, and globular tail function as a single calcium-binding unit.

Jianlin Chu
Pharmacology 901 Student Seminar
Monday, November 5, 2001
140 Bardeen
12:00 Noon

Abstract

The Notch pathway defines an evolutionarily conserved, cell-cell interaction mechanism that controls an extraordinary broad spectrum of cell fates and developmental processes. Signal transduction through the Notch pathway is initiated when the extracellular domain of Notch binds to its ligand on adjacent cells. Ligand binding induces proteolytic liberation of the Notch intracellular domain (NIC), which then translocates to the nucleus and directly regulates gene expression. The four mammalian Notch genes, Notch1-4, are widely expressed during embryogenesis and adult development and play crucial roles in neurogenesis, myogenesis, angiogenesis, hematopoiesis, renal cell development, and other developmental processes. Mutations in the Notch receptors and ligands are associated with human developmental disorders, indicating the broad importance of Notch signaling in humans. However, the molecular mechanisms underlying Notch signaling are poorly understood.

Lam LT et al. discovered that expression of constitutively active human Notch1 (NIC-1) in human K562 erythroleukemic cells effectively activated C-promoter binding factor1 (CBF1)-mediated gene expression. In addition, interleukin-8 (IL-8) was strongly induced upon hemin-induced erythroid maturation, and NIC-1 inhibited this induction. To test the hypothesis that NIC-1 engages in crosstalk with other cellular signaling mechanisms, we asked whether NIC-1 inhibited transcription factors required for IL-8 induction. It was known that the IL-8 promoter is transcriptionally regulated by AP1 and NF-_B transcription factors, both of which integrate a diverse array of cellular signals. We found that NIC-1 inhibited IL-8 induction by specifically repressing AP1-mediated transactivation of IL-8; NIC-1 did not inhibit NF-_B. The CBF1-interacting RAM domain of Notch1 was required for both NIC-1-mediated activation of CBF1-dependent transcription and repression of AP1. Nuclear localization was required for NIC-1-mediated repression of AP1. To test whether NIC-1 inhibits AP1 by disrupting signaling mechanisms necessary for AP1 activation, we assessed the phosphorylation state of MAPK pathway components; no changes were evident. Thus, the data are inconsistent with an anti-signaling mechanism. We are currently testing whether inhibition involves direct antagonism at the level of the chromatin template. Based on the importance of AP1 target genes in hematopoiesis, vasculogenesis, and immune cell functions such as T-cell activation, crosstalk between Notch and AP1 pathways is likely to play previously undescribed critical roles in the control of these processes.

Marty Ensenberger
Pharmacology 901 Student Seminar
October 15, 2001
140 Bardeen
Noon

Exploring the Mechanisms of Adherence and Internalization of Streptococci: Roles for Fibronectin and Protein F1

Group A streptococci (GAS) can use several mechanisms to adhere to and invade non-phagocytic host cells. Among these is the expression of surface proteins that allow the bacteria to exploit a host's own proteins and cellular machinery as a means to colonize cells. Protein F1 (prtF1) is one such surface protein found in Streptococcus pyogenes. PrtF1 mediates high affinity binding to fibronectin (Fn) and facilitates S. pyogenes adherence and penetration into cells. It acts by binding Fn with high affinity (KD ~20nM). Once bound, Fn serves to link the bacteria to integrin receptors found on host cells. Internalization involves proteins and processes normally associated with focal contacts and focal adhesions. PrtF1 contains two functional Fn binding domains. We have analyzed synthetic and recombinant versions of these domains to discover their preferred Fn binding mode. We have also observed what seem to be structural changes in Fn in the presence of our peptides. Our results suggest that although prtF1 has a general affinity for type I modules of Fn, high affinity binding to Fn is mediated by specific interactions with N-terminal type I modules.

References:

Ozeri, V., Rosenshine, I., Ben-Ze'ev, A., Bokoch, G. M., Jou, T., and Hanski, E. (2001) De Novo formation of focal complex-like structures in host cells by invading Streptococci. Mol. Microbiol.  41, 1-14

Ensenberger, M. G., Tomasini-Johansson, B. R., Sottile, J., Ozeri, V., Hanski, E., and Mosher, D. F. (2001) Specific interactions between F1 adhesin of Streptococcus pyogenes and N-terminal modules of fibronectin. J. Biol. Chem.  276, 35606-35613

Tony Huang
October 22, 2001

NF-kB activation by nuclear DNA damage: What is the nature of the nuclear signal?

Signal transduction pathways can be modulated by the subcellular localization of their individual components. A prototypic example is signal-induced activation of the transcription factor NF-kB that plays an important role in immune and inflammatory responses and the regulation of apoptosis. In unstimulated cells, inactive NF-kB preexists in the cytoplasm associated with its inhibitor, IkB. Upon exposure to stimulatory signals, a series of biochemical events targets the inhibitor protein for degradation, allowing the release and migration of NF-kB into the nucleus to regulate gene expression. Activation pathways of NF-kB typically originate from the cytokine-induced ligand-receptor interactions on the cell membrane. However, NF-kB can also be activated by a group of agents that damage DNA in the nucleus. The nature of the nuclear signal generated by these agents to activate cytoplasmic NF-kB is currently unknown. We originally hypothesized that the DNA damage-dependent signal transfer from the nucleus to the cytoplasm involves the Crm1 nuclear export pathway. For this talk, I will present evidence against the requirement of Crm1, but remain open the possibility that the nuclear signal transfer might still be mediated by an active export mechanism.

Jennifer Grant
Pharmacology 901 Student Seminar
Monday, October 29, 2001
140 Bardeen
Noon

Mapping the Interface Between the Transducin a-Subunit and the cGMP Phosphodiesterase g-Subunit

Despite the extensive number of proteins known to participate in G-protein coupled receptor signaling, relatively little is known about the precise interactions between the protein partners. Even the recently solved co-crystal structure (2.0 A) between Gat-ALF4 and fragments of RGS9 and the g-subunit of the cGMP phosphodiesterase (PDEg) leaves many unanswered questions. Namely, what are the characteristics of PDEg interaction with Gat-GTP in isolation , with Gat-GDP ,and what role does the N-terminal domain of PDEg play in the regulation of vision?

Photoaffinity labeling experiments, as well as mutagenesis, provide further insight into how PDEg binds Gat. One such experiment in which the unique cysteine within PDEg was derivatized with a photoactive, radioiodinated phenylazide, revealed that cys68 of PDEg lies in close proximity to the a3 and a4/b6 regions of Gat (Liu et al., 1996). We seek to extend our understanding of the PDEg -binding sites on Gat. This and other experiments underscore the important role of the PDEg C-terminus in regulating Gat.

Expanding on the cross-linking approach used by Liu et al. (1996), I am generating full-length PDEg photoprobes containing benzophenone for use in photoaffinity labeling experiments. Cross-linking between PDEg photoprobe constructs and Gat will be assessed by SDS-PAGE. Furthermore, the photoinsertion sites on Gat will be identified by a combination of in-gel digestion and mass spectrometry.

Two proteins, Gb5 and RGS9, form an obligate heterodimer that regulates the GTPase activity of Gat (Wei et. al, 2000). Kinetic analysis (Skiba  et al., 2001) indicates that the combination of Gb5 and RGS9 creates a complex that specifically recognizes PDEg -laden GatGTP. Cross-linking experiments with a variety of PDEg benzophenone photoprobes will clarify the 3-dimensional interactions of PDEg with each of these proteins.

In collaboration with the Markley research group, NMR experiments are underway to determine structural changes that affect PDEg upon binding Gat. In particular, heteronuclear single quantum coherence (HSQC) experiments suggest there is some secondary structure to the PDE C-terminus even in the absence of Gat. Similarly, NMR techniques will be employed to define structural changes affecting PDEg as Gat binds.

References:

Liu, Y., Arshavsky, V.Y., and Ruoho, A.E. (1996) J. Biol. Chem.. 271: 26900-26907.

Skiba NP, Martemyanov KA, Elfenbein A, et al. (2001) J. Biol. Chem. 276 : 37365-37372.

Slep KC, Kercher MA, He W, et al. (2001)  Nature 409: 1071-1077.

Wei, H., Lu, L., Zhang, X.El-Hodiri, H., Chen, C.-K., Slep, K.C., Simon, M.I., Jamrich, M., Wensel, T.G. (2000) J. Biol. Chem. 275:37093-37100.



[Home]